CERo Therapeutics Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.15 | $0 | |||
| 03/29/2024 | Q1 2024 | -$0.16 | $0 | |||
| 12/29/2023 | Q4 2023 | -$0.05 | $0 | |||
| 09/28/2023 | Q3 2023 | -$0.05 | $0 | |||
| 06/28/2023 | Q2 2023 | -$0.21 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.07 | $0 | |||
| 12/29/2022 | Q4 2022 | -$0.04 | $0 | |||
| 09/28/2022 | Q3 2022 | $0.00 | $0 | |||
| 06/28/2022 | Q2 2022 | -$0.00 | $0 | |||
| 03/29/2022 | Q1 2022 | -$0.02 | $0 | |||
| 12/29/2021 | Q4 2021 | -$0.01 | $0 |
CERo Therapeutics Holdings, Inc. Earnings: Frequently Asked Questions
-
How can I listen to CERo Therapeutics Holdings, Inc.'s earnings conference call?
The conference call for CERo Therapeutics Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read CERo Therapeutics Holdings, Inc.'s conference call transcript?
The conference call transcript for CERo Therapeutics Holdings, Inc.'s latest earnings report can be read online.
-
How much profit does CERo Therapeutics Holdings, Inc. generate each year?
CERo Therapeutics Holdings, Inc. (:CERO) has a recorded net income of $0. CERo Therapeutics Holdings, Inc. has generated $-0.39 earnings per share over the last four quarters.
-
What is CERo Therapeutics Holdings, Inc.'s price-to-earnings ratio?
CERo Therapeutics Holdings, Inc. (:CERO) has a price-to-earnings ratio of -0.23 and price/earnings-to-growth ratio is -0.02.
